Common carp pituitary (CCP) is a powder (for suspension) that is applied as either an intraperitoneal (IP) or intramuscular (IM) injection. CCP is only available for purchase through Progressive Companies, Inc d/b/a Stoller Fisheries. The use of hormones to induce spawning in fish is critical to the success of many aquatic programs that needs hormone treatment to complete final gamete maturation to ensure spawning. The primary goal of field studies conducted under INAD #8391 is to generate data to help determine appropriate CCP treatment regimens for inducing gamete maturation in a variety of cultured and wildstock finfish species. Fish may be treated at a standard dosage rate of 4 to 10 milligrams (mg) CCP per kilogram (kg) body weight with single or multiple IP or IM injections. Although certain situations may require a higher dosage rate, dosage will never exceed 25 (mg) CCP per kilogram (kg) body weight. Multiple injections will generally consist of a single “priming dose,” followed by a single “resolving dose.” Fish treated with CCP can be released back into their natural environment or slaughtered for food immediately after spawning (i.e., no Investigational withdrawal period). To participate in the INAD Program for CCP visit the data collecting site.
Please read the Study Protocol prior to any treatments. It contains the protocol, MSDS, and a copy of the forms to be used as a guide for collecting data that will be entered into the online INAD database. The FDA authorization letter(s) for this INAD is currently only available by emailing Bonnie Johnson.
INAD objective/purpose: Collect supportive and pivotal data needed to establish the effectiveness of Common Carp Pituitary (CCP) to induce gamete maturation in a variety of fish species.
Common Carp Pituitary
Progressive Companies, Inc. d/b/a Stoller Fisheries
1301 18th St; P.O. Box B
Spirit Lake, IA 51360
Target pathogen(s): Not Applicable
Method of administration: IM or IP injection
Investigational Withdrawal period:
Required test parameters:
Limitations or restrictions on use of drug:
Required INAD fee: $700/facility/year
AADAP Contact Information:
Ms. Bonnie Johnson, FWS-AADAP